Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Intravenous Ketamine for Treatment-Resistant Depression: A Randomized, Placebo-Controlled, Triple-masked, Clinical Trial

NCT00768430 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00768430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00768430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Intravenous Ketamine for Treatment-Resistant Depression: A Randomized, Placebo-Controlled, Triple-masked, Clinical Trial
Lead sponsor
Baylor College of Medicine
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2008
Completion date
November 30, 2012
Enrollment
73 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd), treatment resistant depression (trd)